Click to see full size:
Avicenna Day (AAD) 2020
25/08/2020
BACK
Tuesday 25 August 2020
Time: 14.00 – 18:30 CEST / 13.00 - 17.30 BST / 17.30 - 22.00 IST / 8.00 - 12.30 EDT / 7.00 -11.30 CDT
The Avicenna Day is taking place online on Tuesday 25th of August as a satellite event of the VPH 2020 Conference!
The event discussions will be framed around recent progress in the different working groups, engagements by Alliance various task forces to initiate or amplify successful collaborations with clinicians, academics, industries, policymakers, regulators and other stakeholders.
This will be a great opportunity for stakeholders to learn more about the actions the Avicenna Members are jointly conducting to make in silico medicine a standard practice in health care.
If you wish to participate in the Avicenna Day, please register through the VPH Conference Registration Page here.
Avicenna Day 2020
Tuesday 25 August 2020
Time: 14.00 – 18:30 CEST / 13.00 - 17.30 BST / 17.30 - 22.00 IST / 8.00 - 12.30 EDT / 7.00 -11.30 CDT
14:00 – 14:15 | Welcome and presentation of the Avicenna Successful JourneyThierry Marchal, Secretary General, Avicenna Alliance |
14:15 – 14:40 | Successful use of in silico for regulatory approval |
| 14:15 – 14:25 | Medical Device Case study – Steven Levine, Dassault Systèmes |
| 14:25 – 14:35 | Pharmaceutical case study – François Boissel, Novadiscovery |
| 14:35 – 14:40 | Q&A with the audience moderated by Alicia Waterkeyn (Avicenna Secretariat, RPP group) |
14:40 – 15:55 | Session I - A policy community |
| 14:40 – 14:55 | Mission, achievements and planEmmanuelle Voisin, Policy Development Working Group Leader, Voisin Consulting Life Sciences |
| 14:55 – 15:05 | Important directions for Europe in 2021 & 2022James Kennedy, Avicenna Secretariat, RPP Group |
| 15:05 – 15:15 | Towards Good Simulation PracticeLuca Emili, Chair of the GSP Taskforce, InsilicoTrials Technologies |
| 15:15 – 15:30 | A valuable collaboration with EMALiesbet Geris Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven |
| 15:30 – 15:45 | Engaging with Notified BodiesSimon Sonntag, Chair of the Notified Bodies Taskforce, Virtonomy |
| 15:45 – 15:55 | Q&A with the audience moderated by Alicia Waterkeyn, RPP group |
15:55 – 16:25 | Session II - An international community |
| 15:55 – 16:00 | Mission, achievements and planMarkus Reiterer, International Working Group Leader, Medtronic |
| 16:00 – 16:10 | Computer modelling as regulatory evidence at FDABrent Craven, U.S. Food and Drug Administration |
| 16:10 – 16:20 | Global Recommendations for in silico EvidenceMarc Horner, Ansys |
| 16:20 – 16:25 | Q&A with the audience moderated by Alicia Waterkeyn, RPP group |
16:25 – 16:40 | Break |
16:40 – 17:45 | Session III - A research & technology community |
| 16:40 – 16:50 | Mission, achievements and planLiesbet Geris, Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven |
| 16:50 – 17:05 | Certified Materials LibraryVenkat Perumal, Chair of the Materials Library Taskforce, Stryker |
| 17:05 – 17:20 | Funding for in silico in Horizon Europe projectsLiesbet Geris, VPHi, KU Leuven, ULiege |
| 17:20 – 17:35 | The role of AI for in silico medicineJérôme Noailly, VPHi, Pompeu Fabra University, Barcelona |
| 17:35 – 17:45 | Q&A with the audience moderated by Alicia Waterkeyn, RPP group |
17:45 – 18:20 | Session IV – Interactive Panel Discussion with Avicenna Alliance Board MembersLiesbet Geris, Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven |
18:20 – 18:30 | Concluding RemarksThierry Marchal, Secretary General, Avicenna Alliance |
Speakers
Recordings
